12 March 2008
Immtech Announces Update On Business Operations

22 February 2008
Immtech Focusing on New Infectious Disease Programs Following Discontinuation Of Development For Pafuramidine

19 February 2008
Immtech Investor Conference Call Scheduled For February 22, 2008

13 February 2008
Immtech Appoints Blythe Weigh As Strategic Advisor

11 February 2008
Immtech Reports Fiscal Third Quarter 2008 Results

06 February 2008
Immtech Investor Conference Call Scheduled for February 11, 2008

28 December 2007
Immtech Investor Conference Call Scheduled for January 3, 2008, at 1 PM

26 December 2007
Immtech Announces Pafuramidine (DB289) Program on Clinical Hold

05 December 2007
Immtech and BioAlliance Sign Licensing Agreement for Pafuramidine

往新聞稿網頁

從Adobe網站下載免費拷貝

董事會成員

Eric L. Sorkin
主席及行政總裁

• Mr. Sorkin has been affiliated with Immtech since 1998, when he became an investor. In 2000, Mr. Sorkin became a director for the Company, and more recently was appointed Chairman of the Board and CEO. Mr. Sorkin began his career on Wall Street in 1982 working at Dean Witter, which is now a subsidiary of Morgan Stanley, and from an entry-level position, he was promoted to Managing Director within six years. He was among the core group of professionals at the firm, which developed the firmOs investment portfolio with assets of over USD $3 billion. Corporations, banks and entities with which Mr. Sorkin worked on completed transactions included Aetna, International Paper, Continental Insurance, Barclays Banks, Chase Manhattan, Harvard University, Southern Bell, Cigna, the State of Wisconsin, AIG, Modern Woodman of America, Zurich American Life, and San Francisco City and County. Mr. Sorkin was responsible for investment selection, negotiations, transaction and financial structuring, debt placement, and asset management. Mr. Sorkin was Vice President, Owner, and/or Director of over 20 public investment partnerships with investment funds totaling over USD $1 billion. In 1993, Mr. Sorkin created his own investment firm and began making private equity investments in the U.S. and in China. Mr. Sorkin graduated Yale University with a B.A. in Economics.

Cecilia Chan
副主席

David Fleet
David Fleet Pharmaceutical Industry Consultancy Services 董事長
OnMedica Group Ltd. 非執行總監
IatRx Pharma 總監

Judy Lau
Convergent Business Group主席
中國香港

Levi Hong Kaye Lee, M.D.
瑪麗醫院
中國香港

Donald F. Sinex
董事會董事
Devonwood, Inc.

Dr. Dorothy S. Zinberg
Center for Science and International Affairs
Kennedy School of Government
Harvard University

使用條件| 私隱條例
c 2007 Immtech. 版權所有